Syndax Pharmaceuticals Inc Annual Return On Equity in % from 2016 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Syndax Pharmaceuticals Inc quarterly/annual Return On Equity history and growth rate from 2016 to 2023.
  • Syndax Pharmaceuticals Inc Return On Equity for the quarter ending September 30, 2024 was -64.3 %, a 51.8% decline year-over-year.
  • Syndax Pharmaceuticals Inc annual Return On Equity for 2023 was -47.9 %, a 23.6% decline from 2022.
  • Syndax Pharmaceuticals Inc annual Return On Equity for 2022 was -38.7 %, a 508% decline from 2021.
  • Syndax Pharmaceuticals Inc annual Return On Equity for 2021 was 9.49 %.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -47.9 -9.15 -23.6% Jan 1, 2023 Dec 31, 2023
2022 -38.7 -48.2 -508% Jan 1, 2022 Dec 31, 2022
2021 9.49 +59.5 Jan 1, 2021 Dec 31, 2021
2020 -50 +62.4 +55.5% Jan 1, 2020 Dec 31, 2020
2019 -112 -4.62 -4.29% Jan 1, 2019 Dec 31, 2019
2018 -108 -44.2 -69.6% Jan 1, 2018 Dec 31, 2018
2017 -63.5 -18.8 -42.1% Jan 1, 2017 Dec 31, 2017
2016 -44.7 Jan 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.